# The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes

> **NCT00360217** · NA · COMPLETED · sponsor: **Maine Center for Lipids and Cardiovascular Health** · enrollment: 60 (estimated)

## Conditions studied

- Hypertriglyceridemia (TG>200<500)
- Hyperlipidemia
- Coronary Artery Disease
- Coronary Risk Equivalent
- Diabetes

## Interventions

- **DRUG:** docosahexanoic acid (DHA)

## Key facts

- **NCT ID:** NCT00360217
- **Lead sponsor:** Maine Center for Lipids and Cardiovascular Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-05
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2011-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00360217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00360217, "The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00360217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*